Augmedix

Augmedix

AI platform for medical documentation and support

About Augmedix

Simplify's Rating
Why Augmedix is rated
B+
Rated C on Competitive Edge
Rated A on Growth Potential
Rated A on Rating Differentiation

Industries

AI & Machine Learning

Healthcare

Company Size

501-1,000

Company Stage

IPO

Headquarters

San Francisco, California

Founded

2012

Overview

Augmedix uses ambient AI technology to help healthcare providers manage administrative tasks more efficiently. The platform listens to natural conversations between clinicians and patients, transforming these discussions into organized medical notes and useful data. This process not only supports clinical decision-making but also improves the overall efficiency of healthcare operations by providing timely notifications at the point of care. Augmedix serves hospitals and health systems by analyzing data from numerous interactions in different care environments, aiming to enhance clinical, operational, and financial results. Unlike many competitors, Augmedix operates on a subscription model, allowing healthcare providers to access its AI solutions to lessen administrative workloads and improve patient care.

Simplify Jobs

Simplify's Take

What believers are saying

  • The Vizient contract expands Augmedix's reach to a vast network of healthcare providers.
  • Commure's acquisition enhances Augmedix's scalability and innovation capabilities.
  • Successful pilot with HCA Healthcare shows efficacy in reducing documentation time.

What critics are saying

  • Increased competition from AI scribe companies may impact market share and pricing.
  • Commure acquisition could disrupt existing client relationships or internal operations.
  • Reliance on EHR integration poses risks if major providers change their policies.

What makes Augmedix unique

  • Augmedix uses ambient AI to automate medical documentation, reducing clinician administrative tasks.
  • The platform integrates with over 50 EHR systems, enhancing compatibility and ease of use.
  • Augmedix's generative AI solution addresses clinician burnout, especially in emergency departments.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$283M

Above

Industry Average

Funded Over

5 Rounds

Acquisition funding comparison data is currently unavailable. We're working to provide this information soon!
Acquisition Funding Comparison
Coming Soon

Company News

Hit Consultant
Jan 13th, 2025
Augmedix Awarded Vizient Contract For Ambient Ai Documentation Solutions

Augmedix Awarded Vizient Contract for Ambient AI Documentation Solutions. by Fred Pennic 01/13/2025 Leave a Comment. What You Should Know: – Augmedix, a leader in ambient AI medical documentation and a wholly-owned subsidiary of Commure has secured a contract with Vizient, the nation’s largest provider-driven healthcare performance improvement company. – The agreement grants Vizient’s extensive network of healthcare providers access to Augmedix’s comprehensive suite of AI-powered documentation solutions.Streamlining Documentation with AIVizient serves a vast majority of acute care providers, academic medical centers, and non-acute care facilities across the United States. Its diverse customer base, representing over $140 billion in annual purchasing volume, includes pediatric facilities, community hospitals, and integrated health delivery networks.Through this contract, Vizient members can now leverage Augmedix Go, a cost-effective and scalable AI documentation solution that automatically generates medical notes from natural clinician-patient conversations. This technology empowers providers to:Reduce administrative burden: Freeing up clinicians from time-consuming documentation tasks.Improve operational efficiency: Streamlining workflows and optimizing clinical documentation processes.Enhance clinician and patient experiences: Allowing clinicians to focus more on patient interaction and care delivery.Broad Compatibility and IntegrationAugmedix Go seamlessly integrates with over 50 EHR systems, including Epic, Oracle Health, and MEDITECH, making it a versatile solution for various healthcare settings. This compatibility ensures that providers can easily incorporate Augmedix’s technology into their existing workflows.“We are excited to introduce Vizient’s provider clients to the transformative potential of Ambient Clinical Documentation,” said Ian Shakil, founder of Augmedix and Chief Strategy Officer of Commure

Hit Consultant
Jan 13th, 2025
Augmedix Awarded Vizient Contract for Ambient AI Documentation Solutions

Augmedix Go seamlessly integrates with over 50 EHR systems, including Epic, Oracle Health, and MEDITECH, making it a versatile solution for various healthcare settings.

Healthcare IT Today
Aug 9th, 2024
Augmedix Acquired by Commure for $139M

Augmedix, Inc. will be acquired by Commure, Inc. in an all-cash transaction valued at approximately $139 million. Augmedix stockholders will receive $2.35 per share, a 169% premium over the 30-day VWAP ending July 18, 2024. Augmedix will become a wholly-owned subsidiary of Commure. CEO Manny Krakaris stated that the acquisition will enhance Augmedix's ability to scale and innovate its ambient AI medical documentation solutions.

Hit Consultant
Jul 19th, 2024
Commure To Acquire Augmedix In $139M All-Cash Deal

Commure to Acquire Augmedix in $139M All-Cash Deal by Fred Pennic 07/19/2024 Leave a Comment What You Should Know:  – Augmedix (AUGX), a leader in AI-powered medical documentation and data solutions, is being acquired by healthcare technology provider Commure in an all-cash deal valued at approximately $139M. News of the acquisition brought Augmedix up by 150% at $2.27 at 10 am ET after closing at $0.92 on Thursday.  – Augmedix leverages AI technology to streamline medical documentation and data management for healthcare providers. Their platform uses ambient AI to convert natural conversations into organized medical notes, improving efficiency and clinical decision-making. – The combined company aims to leverage AI and automation to reduce administrative tasks for healthcare professionals, allowing them to spend more time with patients. This could lead to improved patient outcomes, increased provider satisfaction, and a more efficient healthcare system overall. Terms of the Agreement: Augmedix shareholders will receive $2.35 per share.This represents a premium of 169% over Augmedix’s 30-day stock price average.Commure will acquire all outstanding Augmedix shares.The transaction is expected to close in late Q3 or early Q4 of 2024, subject to shareholder approval and customary closing conditions.Upon closing, Augmedix will become a private subsidiary of Commure and its stock will be delisted

Fierce Healthcare
Jul 19th, 2024
Health tech company Commure to acquire Augmedix in $139M deal as AI scribe competition heats up

Health tech company Commure to acquire Augmedix in $139M deal as AI scribe competition heats up.

There are no jobs for Augmedix right now.

Find jobs on Simplify and start your career today

💡
Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →